Is the estimated glomerular filtration rate (eGFR) normal in acute kidney injury (AKI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, eGFR is NOT normal in acute kidney injury (AKI)—it is reduced or declining

By definition, AKI involves a decline in kidney function, which manifests as a fall in eGFR, a rise in serum creatinine, or reduced urine output. The estimated glomerular filtration rate (eGFR) decreases during AKI, though the magnitude and timing of this decline varies based on the severity and stage of injury 1.

Understanding eGFR Changes in AKI

The Fundamental Problem with eGFR in Acute Settings

Creatinine-based eGFR equations systematically overestimate true GFR during AKI because they were developed for stable chronic kidney disease (CKD), not acute conditions 1, 2. When AKI occurs:

  • True GFR drops rapidly (within hours)
  • Serum creatinine rises slowly (over days) before reaching steady state
  • eGFR calculations lag behind the actual kidney function decline 1

This creates a dangerous window where eGFR appears falsely reassuring while true kidney function has already deteriorated significantly 2.

Quantifying the Overestimation

Research demonstrates the magnitude of this problem:

  • In critically ill adults with severe oligoanuric AKI (true GFR ≤15 mL/min/1.73 m²), creatinine-based equations overestimated GFR by 17-50 mL/min/1.73 m² 2
  • This overestimation persisted through the fourth day of AKI 2
  • Even kinetic eGFR equations showed limits of agreement exceeding 40 mL/min/1.73 m² when compared to measured GFR 3

How AKI is Defined Using eGFR

Adult Criteria (KDIGO)

AKI staging incorporates eGFR decline 1, 4:

  • Stage 1: 1.5-1.9× baseline creatinine OR ≥0.3 mg/dL increase within 48 hours
  • Stage 2: 2.0-2.9× baseline creatinine
  • Stage 3: 3.0× baseline creatinine OR creatinine ≥4.0 mg/dL OR initiation of dialysis

Pediatric Criteria (pRIFLE)

Children are staged by percentage fall in eGFR 1:

  • Stage R (Risk): ≥25% eGFR decrease
  • Stage I (Injury): ≥50% eGFR decrease
  • Stage F (Failure): ≥75% eGFR decrease OR eGFR <35 mL/min/1.73 m²

The example provided shows a 7-year-old with baseline eGFR of 88 mL/min/1.73 m² dropping to 65 mL/min/1.73 m² (25% fall) during AKI 1.

Critical Clinical Pitfalls

The "Normal" eGFR Trap

A patient can have significant AKI even with an eGFR that appears within normal range if:

  1. Their baseline eGFR was supranormal (>105 mL/min/1.73 m²)
  2. They've experienced acute decline but haven't yet crossed traditional thresholds
  3. Creatinine hasn't equilibrated to reflect true GFR loss

Recent evidence shows patients with high baseline eGFR (≥105 mL/min/1.73 m²) have doubled AKI risk (adjusted OR 2.143) 5, creating a U-shaped relationship between baseline eGFR and AKI incidence.

Medication Dosing Hazard

The overestimation of eGFR during AKI creates substantial risk for medication toxicity 2. Clinicians relying on calculated eGFR may:

  • Underdose antimicrobials when higher doses are needed
  • Overdose renally-cleared medications, causing toxicity
  • Delay recognition of need for renal replacement therapy

When eGFR Equations Fail Most

Creatinine-based eGFR is particularly unreliable when 1:

  • Creatinine kinetics are unstable (first 48-72 hours of AKI)
  • Volume of distribution is extreme or variable (critical illness, fluid overload)
  • Multiple renal insults occur over time
  • Baseline kidney function is unknown

Alternative Approaches

Cystatin C-Based eGFR

Cystatin C-based eGFR demonstrates superior discrimination for mortality and progression in AKI compared to creatinine-based estimates 6. It responds more rapidly to GFR changes and is less affected by muscle mass variations.

Direct Measurement

When precise GFR assessment is critical, measured GFR using iohexol or radioisotopic methods provides the gold standard 7, 3, though this is rarely practical in acute settings.

Bottom Line for Clinical Practice

Never assume eGFR is "normal" or accurate during AKI. Instead:

  • Use absolute creatinine changes and urine output as primary AKI indicators
  • Recognize that eGFR calculations lag behind true kidney function by days
  • Consider cystatin C-based eGFR when available for more accurate assessment
  • Adjust medication dosing conservatively, assuming worse kidney function than eGFR suggests
  • Monitor trends rather than single values
  • Be especially vigilant in patients with high baseline eGFR (≥105 mL/min/1.73 m²) who may develop AKI while maintaining "normal-appearing" eGFR values 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.